Annual report
3407.TEDINET S100OCR3
Period2021-04-01 → 2022-03-31
Filed2022-06-24
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.46T | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥2.11T | 2020-04-01 → 2021-03-31 | Cons. | Net sales |
| Revenue | ¥2.15T | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.17T | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.04T | 2017-04-01 → 2018-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥202.6bn | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Operating income | ¥171.8bn | 2020-04-01 → 2021-03-31 | Cons. | Operating income |
| Ordinary income | ¥212.1bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥178.0bn | 2020-04-01 → 2021-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥184.0bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥220.0bn | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥212.5bn | 2017-04-01 → 2018-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥215.1bn | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥150.9bn | 2020-04-01 → 2021-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥161.9bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥79.8bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥103.9bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥147.5bn | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥170.2bn | 2017-04-01 → 2018-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥163.8bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Net income | ¥82.1bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss |
| Total assets | ¥3.35T | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥2.92T | at 2021-03-31 | Cons. | Assets |
| Total assets | ¥2.82T | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥2.58T | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥2.31T | at 2018-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.63T | at 2022-03-31 | Cons. | Liabilities |
| Total liabilities | ¥1.42T | at 2021-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.72T | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.49T | at 2021-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.38T | at 2020-03-31d | Cons. | Net assets |
| Net assets / equity | ¥1.40T | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥1.31T | at 2018-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥244.6bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥221.8bn | at 2021-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥242.9bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥216.2bn | at 2021-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥204.8bn | at 2020-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥180.5bn | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥148.6bn | at 2018-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥183.3bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥253.7bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥124.5bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥212.1bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥249.9bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥221.0bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥157.8bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥318.2bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥198.9bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥110.3bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥42.3bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥95.9bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥221.9bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥17.4bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥134.4bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥116.68 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥57.49 | 2020-04-01 → 2021-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥74.85 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥105.66 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥121.93 | 2017-04-01 → 2018-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥1,216.33 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,057.61 | at 2021-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥979.69 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥989.51 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥922.11 | at 2018-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 50.4% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.3% | at 2021-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 48.2% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.6% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.8% | at 2018-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 10.3% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.6% | 2020-04-01 → 2021-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.6% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.1% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 14.0% | 2017-04-01 → 2018-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 46,751 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 44,497 | at 2021-03-31 | Cons. | Number of employees |
| Employees | 40,689 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 39,283 | at 2019-03-31d | Cons. | Number of employees |
| Employees | 34,670 | at 2018-03-31d | Cons. | Number of employees |
| Revenue | ¥652.6bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥548.1bn | 2020-04-01 → 2021-03-31 | Standalone | Net sales |
| Revenue | ¥600.0bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥665.8bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥621.9bn | 2017-04-01 → 2018-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥35.1bn | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Operating income | ¥6.4bn | 2020-04-01 → 2021-03-31 | Standalone | Operating income |
| Ordinary income | ¥81.9bn | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥64.5bn | 2020-04-01 → 2021-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥76.8bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥106.7bn | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥94.2bn | 2017-04-01 → 2018-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥76.9bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥69.4bn | 2020-04-01 → 2021-03-31 | Standalone | Income before income taxes |
| Net income | ¥52.5bn | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥67.7bn | 2020-04-01 → 2021-03-31 | Standalone | Profit loss |
| Net income | ¥57.9bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥89.3bn | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥84.3bn | 2017-04-01 → 2018-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥2.15T | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥2.29T | at 2021-03-31 | Standalone | Assets |
| Total assets | ¥1.92T | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.76T | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.65T | at 2018-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.38T | at 2022-03-31 | Standalone | Liabilities |
| Total liabilities | ¥1.50T | at 2021-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥771.8bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥790.3bn | at 2021-03-31 | Standalone | Net assets |
| Net assets / equity | ¥744.2bn | at 2020-03-31d | Standalone | Net assets |
| Net assets / equity | ¥778.2bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥758.3bn | at 2018-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥37.2bn | at 2022-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥41.2bn | at 2021-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥37.83 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥48.8 | 2020-04-01 → 2021-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥41.68 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥63.95 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥60.36 | 2017-04-01 → 2018-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥34 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥34 | 2020-04-01 → 2021-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥34 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥34 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥34 | 2017-04-01 → 2018-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥556.34 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥569.58 | at 2021-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥536.36 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥557.42 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥543.11 | at 2018-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 35.9% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.5% | at 2021-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.8% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.2% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.0% | at 2018-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 6.7% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.8% | 2020-04-01 → 2021-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.6% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.6% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.1% | 2017-04-01 → 2018-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 1,393,932,000 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,393,932,000 | at 2021-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,393,932,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,402,616,000 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,402,616,000 | at 2018-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 8,646 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 8,524 | at 2021-03-31 | Standalone | Number of employees |
| Employees | 8,253 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 7,864 | at 2019-03-31d | Standalone | Number of employees |
| Employees | 7,520 | at 2018-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 90
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2021-04-01 → 2022-03-31 | ¥3.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2021-04-01 → 2022-03-31 | ¥1.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2022-03-31 | 1386 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2022-03-31 | ¥55.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2022-03-31 | ¥13.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥41.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2022-03-31 | ¥101.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2022-03-31 | ¥3.2bn |
| Health Carereportable segment | capex | 2021-04-01 → 2022-03-31 | ¥24.9bn |
| Health Carereportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥34.5bn |
| Health Carereportable segment | employees | at 2022-03-31 | 10815 pure |
| Health Carereportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥415.9bn |
| Health Carereportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥415.9bn |
| Health Carereportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥20m |
| Health Carereportable segment | segment assets | at 2022-03-31 | ¥861.1bn |
| Health Carereportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥52.2bn |
| Homesreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥18.6bn |
| Homesreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥13.8bn |
| Homesreportable segment | employees | at 2022-03-31 | 11734 pure |
| Homesreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥833.4bn |
| Homesreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥833.4bn |
| Homesreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥66m |
| Homesreportable segment | segment assets | at 2022-03-31 | ¥639.3bn |
| Homesreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥73.2bn |
| Materialreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥120.8bn |
| Materialreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥63.7bn |
| Materialreportable segment | employees | at 2022-03-31 | 19829 pure |
| Materialreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥1.20T |
| Materialreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥1.20T |
| Materialreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥6.7bn |
| Materialreportable segment | segment assets | at 2022-03-31 | ¥1.78T |
| Materialreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥110.3bn |
| —segment total | capex | 2021-04-01 → 2022-03-31 | ¥164.2bn |
| —segment total | depreciation | 2021-04-01 → 2022-03-31 | ¥112.0bn |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥2.45T |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥2.45T |
| —segment total | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥6.8bn |
| —segment total | segment assets | at 2022-03-31 | ¥3.28T |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | ¥235.6bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-04-01 → 2022-03-31 | ¥167.8bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-04-01 → 2022-03-31 | ¥113.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2022-03-31 | ¥2.51T |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2022-03-31 | ¥2.46T |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥48.6bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-03-31 | ¥3.38T |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2022-03-31 | ¥238.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2020-04-01 → 2021-03-31 | ¥809m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2020-04-01 → 2021-03-31 | ¥1.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2020-04-01 → 2021-03-31 | ¥55.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2020-04-01 → 2021-03-31 | ¥14.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥41.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2021-03-31 | ¥92.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2020-04-01 → 2021-03-31 | ¥3.8bn |
| Health Carereportable segment | capex | 2020-04-01 → 2021-03-31 | ¥15.9bn |
| Health Carereportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥31.1bn |
| Health Carereportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥407.9bn |
| Health Carereportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥407.9bn |
| Health Carereportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥24m |
| Health Carereportable segment | segment assets | at 2021-03-31 | ¥734.7bn |
| Health Carereportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥67.6bn |
| Homesreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥18.7bn |
| Homesreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥11.2bn |
| Homesreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥692.7bn |
| Homesreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥692.6bn |
| Homesreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥22m |
| Homesreportable segment | segment assets | at 2021-03-31 | ¥568.6bn |
| Homesreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥63.5bn |
| Materialreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥100.5bn |
| Materialreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥59.0bn |
| Materialreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥996.7bn |
| Materialreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥991.2bn |
| Materialreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥5.5bn |
| Materialreportable segment | segment assets | at 2021-03-31 | ¥1.57T |
| Materialreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥66.5bn |
| —segment total | capex | 2020-04-01 → 2021-03-31 | ¥135.1bn |
| —segment total | depreciation | 2020-04-01 → 2021-03-31 | ¥101.3bn |
| —segment total | revenue | 2020-04-01 → 2021-03-31 | ¥2.10T |
| —segment total | revenue external | 2020-04-01 → 2021-03-31 | ¥2.09T |
| —segment total | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥5.6bn |
| —segment total | segment assets | at 2021-03-31 | ¥2.87T |
| —segment total | segment profit | 2020-04-01 → 2021-03-31 | ¥197.6bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2020-04-01 → 2021-03-31 | ¥135.9bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2020-04-01 → 2021-03-31 | ¥102.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-04-01 → 2021-03-31 | ¥2.15T |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-04-01 → 2021-03-31 | ¥2.11T |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥46.6bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2021-03-31 | ¥2.96T |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-04-01 → 2021-03-31 | ¥201.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2022-03-31 | 9 pure |
| Materialreportable segment | employees | at 2022-03-31 | 5650 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 2,214
| Item | Context | Value | Unit |
|---|---|---|---|
| Total return on share price index | Prior4YearInstant_NonConsolidatedMember | 1.159 | |
| Total return on share price index | Prior3YearInstant_NonConsolidatedMember | 1.100 | |
| Total return on share price index | Prior2YearInstant_NonConsolidatedMember | 0.996 | |
| Total return on share price index | Prior1YearInstant_NonConsolidatedMember | 1.415 | |
| Total return on share price index | CurrentYearInstant_NonConsolidatedMember | 1.443 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E00877-000MaterialReportableSegmentsMember | 19829 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E00877-000HomesReportableSegmentsMember | 11734 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E00877-000HealthCareReportableSegmentsMember | 10815 | |
| Number of employees | CurrentYearInstant_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 1386 | |
| Number of employees | CurrentYearInstant_CorporateSharedMember | 2987 | |
| Number of employees | CurrentYearInstant | 46751 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 8646 | |
| Average age years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 41.3 | |
| Average length of service years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 14.6 | |
| Average annual salary information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 7511733 | JPY |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E00877-000MaterialReportableSegmentsMember | 5650 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 9 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_CorporateSharedMember | 2987 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 8646 | |
| Research and development expenses research and development activities | CurrentYearDuration | 98693000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E00877-000MaterialReportableSegmentsMember | 33790000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E00877-000HomesReportableSegmentsMember | 3688000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E00877-000HealthCareReportableSegmentsMember | 47374000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_OtherOperatingSegmentsAxisMember | 129000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E00877-000MaterialReportableSegmentsMember | 120751000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E00877-000HomesReportableSegmentsMember | 18600000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E00877-000HealthCareReportableSegmentsMember | 24882000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 3533000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_ReportableSegmentsMember | 167766000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_UnallocatedAmountsAndEliminationMember | 18878000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration | 186644000000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 1393932032 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 1393932032 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 1393932032 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 1393932032 | |
| Number of shares constituting one unit | CurrentYearInstant_OrdinaryShareMember | 100 | |
| Number of shareholders national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shareholders financial institutions | CurrentYearInstant_OrdinaryShareMember | 166 | |
| Number of shareholders financial service providers | CurrentYearInstant_OrdinaryShareMember | 53 | |
| Number of shareholders other corporations | CurrentYearInstant_OrdinaryShareMember | 1089 | |
| Number of shareholders foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 797 | |
| Number of shareholders foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 250 | |
| Number of shareholders individuals and others | CurrentYearInstant_OrdinaryShareMember | 120215 | |
| Number of shareholders total | CurrentYearInstant_OrdinaryShareMember | 122570 | |
| Number of shares held number of units national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shares held number of units financial institutions | CurrentYearInstant_OrdinaryShareMember | 6113582 | |
| Number of shares held number of units financial service providers | CurrentYearInstant_OrdinaryShareMember | 413395 | |
| Number of shares held number of units other corporations | CurrentYearInstant_OrdinaryShareMember | 465574 | |
| Number of shares held number of units foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 4638033 | |
| Number of shares held number of units foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 1828 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |